These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38341468)

  • 1. Synthesis, molecular docking and DFT analysis of novel bis-Schiff base derivatives with thiobarbituric acid for α-glucosidase inhibition assessment.
    Gul S; Jan F; Alam A; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Khan M; Bo L
    Sci Rep; 2024 Feb; 14(1):3419. PubMed ID: 38341468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach.
    Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M
    Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid.
    Khan H; Jan F; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Ullah S; Al-Harrasi A; Khan M; Ali S
    Sci Rep; 2024 May; 14(1):11410. PubMed ID: 38762658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isatin based Schiff bases as inhibitors of α-glucosidase: Synthesis, characterization, in vitro evaluation and molecular docking studies.
    Rahim F; Malik F; Ullah H; Wadood A; Khan F; Javid MT; Taha M; Rehman W; Ur Rehman A; Khan KM
    Bioorg Chem; 2015 Jun; 60():42-8. PubMed ID: 25955493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study.
    Rahim F; Zaman K; Taha M; Ullah H; Ghufran M; Wadood A; Rehman W; Uddin N; Shah SAA; Sajid M; Nawaz F; Khan KM
    Bioorg Chem; 2020 Jan; 94():103394. PubMed ID: 31699396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus.
    Daoud S; Thiab S; Jazzazi TMA; Al-Shboul TMA; Ullah S
    Acta Pharm; 2022 Sep; 72(3):449-458. PubMed ID: 36651543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of thiobarbituric acid derivatives: In vitro α-glucosidase inhibition and molecular docking studies.
    Barakat A; Ali M; Mohammed Al-Majid A; Yousuf S; Iqbal Choudhary M; Khalil R; Ul-Haq Z
    Bioorg Chem; 2017 Dec; 75():99-105. PubMed ID: 28926784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs.
    Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM
    Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterisation of thiobarbituric acid enamine derivatives, and evaluation of their α-glucosidase inhibitory and anti-glycation activity.
    Ali M; Barakat A; El-Faham A; Al-Rasheed HH; Dahlous K; Al-Majid AM; Sharma A; Yousuf S; Sanam M; Ul-Haq Z; Choudhary MI; de la Torre BG; Albericio F
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):692-701. PubMed ID: 32156165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
    Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
    Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies.
    Taha M; Ismail NH; Lalani S; Fatmi MQ; Atia-Tul-Wahab ; Siddiqui S; Khan KM; Imran S; Choudhary MI
    Eur J Med Chem; 2015 Mar; 92():387-400. PubMed ID: 25585009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives.
    Azizian H; Pedrood K; Moazzam A; Valizadeh Y; Khavaninzadeh K; Zamani A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Hosseini S; Sarrafi Y; Adibi H; Larijani B; Rastegar H; Mahdavi M
    Sci Rep; 2022 Sep; 12(1):14870. PubMed ID: 36050498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
    Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
    Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors.
    Khan M; Khan S; Ul Mulk A; Ur Rahman A; Wadood A; Shams S; Ashraf M; Rahman J; Khan I; Hameed A; Hussain Z; Khan A; Zaman K; Khan KM; Perveen S
    Med Chem; 2019; 15(2):175-185. PubMed ID: 30207240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors.
    Noori M; Davoodi A; Iraji A; Dastyafteh N; Khalili M; Asadi M; Mohammadi Khanaposhtani M; Mojtabavi S; Dianatpour M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2022 Aug; 12(1):14019. PubMed ID: 35982225
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
    Wang G; Peng Z; Gong Z; Li Y
    Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
    Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.